Biblio Discovery — Demo Discovery Service

6 hasil untuk "Li-Jun Bi"

Menampilkan 1–6 · 0,22 detik · RSS

  1. Artikel Jurnal Teks lengkap

    MSMEG_2731, an Uncharacterized Nucleic Acid Binding Protein from Mycobacterium smegmatis , Physically Interacts with RPS1

    Mingzhang Yang; Yuanyuan Chen; Ying Zhou dkk.

    PLoS ONE, Vol. 7 No. 5 · 2012 · Inggris · PLOS Scopus

    While the M. smegmatis genome has been sequenced, only a small portion of the genes have been characterized experimentally. Here, we purify and characterize MSMEG_2731, a conserved hypothetical alanine and arginine rich M. smegmatis protein. Using ultracentrifugation, we show that MSMEG_2731 is a…

  2. Artikel Jurnal Teks lengkap

    Correction: A Sir2-Like Protein Participates in Mycobacterial NHEJ

    Zhongdao Li; Jikai Wen; Yaning Lin dkk.

    PLoS ONE, Vol. 6 No. 7 · 2011 · Inggris · PLOS Scopus

  3. Artikel Jurnal Teks lengkap

    A Sir2-Like Protein Participates in Mycobacterial NHEJ

    Zhongdao Li; Jikai Wen; Yaning Lin dkk.

    PLoS ONE, Vol. 6 No. 5 · 2011 · Inggris · PLOS Scopus

    In eukaryotic cells, repair of DNA double-strand breaks (DSBs) by the nonhomologous end-joining (NHEJ) pathway is critical for genome stability. In contrast to the complex eukaryotic repair system, bacterial NHEJ apparatus consists of only two proteins, Ku and a multifunctional DNA ligase (LigD)…

  4. Artikel Jurnal Teks lengkap

    Detection of B. anthracis Spores and Vegetative Cells with the Same Monoclonal Antibodies

    Dian-Bing Wang; Ruifu Yang; Zhi-Ping Zhang dkk.

    PLoS ONE, Vol. 4 No. 11 · 2009 · Inggris · PLOS Scopus

    Bacillus anthracis, the causative agent of anthrax disease, could be used as a biothreat reagent. It is vital to develop a rapid, convenient method to detect B. anthracis. In the current study, three high affinity and specificity monoclonal antibodies (mAbs, designated 8G3, 10C6 and 12F6) have been…

  5. Artikel Jurnal Teks lengkap

    Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells

    Feng Ge; Chuan-Le Xiao; Li-Jun Bi dkk.

    PLoS ONE, Vol. 5 No. 9 · 2010 · Inggris · PLOS Scopus

    Background: The proteasome inhibitor bortezomib represents an important advance in the treatment of multiple myeloma (MM). Bortezomib inhibits the activity of the 26S proteasome and induces cell death in a variety of tumor cells; however, the mechanism of cytotoxicity is not well understood…